IVD Quality Control Market to be Worth $2.19 Billion by 2030
o
IVD Quality Control Market to be Worth
$2.19 Billion by 2030
|
Meticulous Research®—a leading market
research company, published a research report titled, ‘IVD Quality Control Market by Offering (Product
[Serum, Blood, Urine-based], Data Management, Service), Technology
(Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious
Diseases, Oncology, Cardiology), and End User – Global Forecast to 2030’
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=3447
According to this latest publication from
Meticulous Research®, the IVD quality control market is projected to reach $2.19
billion by 2030, at a CAGR of 4.3% from 2023 to 2030. The growth of the IVD
quality control market is driven by the rising prevalence of chronic diseases,
coupled with the increasing geriatric population, growing demand for
third-party quality controls, need for internal and external quality
assessment reports, increasing number of clinical laboratories, growing demand
for Point-of-Care (POC) and rapid diagnostics. However, stringent technical
requirements and regulatory processes for quality controls restrain this
market's growth.
Growing demand for multi-analyte and
multi-instrument controls offers opportunities for market growth. However, the
evolving regulatory landscape and lack of access to quality control/quality
assurance materials are the major challenges to market growth.
Key Players
Key companies operating in the IVD quality
control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories,
Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher
Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.),
QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), and Microbiologics, Inc.
(U.S.), and Bio-Techne Corporation (U.S.)
The IVD quality control market is segmented
by Offering (Quality Control Products {Quality Control Products, by Type
[Serum/Plasma-based Controls, Whole Blood-based Controls, Urine-based
Controls, Other Controls], Quality Control Products, by Function [Independent
Controls, Instrument-specific Controls]}, Quality Assessment Services, Data
Management Solutions); Technology (Immunoassay/Immunochemistry,
Biochemistry/Clinical Chemistry, Molecular Diagnostics, Hematology,
Coagulation/Hemostasis, Microbiology, Other Technologies); Application
(Infectious Diseases, Oncology, Cardiology, Autoimmune Disorders, Neurology,
Other Applications); End User (Hospitals & Clinics, Diagnostic
Laboratories, Academic Institutes & Research Laboratories, Other End Users),
and Geography. The study also evaluates industry competitors and analyzes the
regional and country-level markets.
Among the offering, in 2023, the
quality control products segment is expected to account for the largest share
of the IVD quality control market. Among the quality control products segment
by type, serum/plasma-based controls are expected to account for the largest
share as various diagnostic tests, such as those for glucose, cholesterol,
electrolytes, liver enzymes, and cardiac markers, are performed using serum or
plasma samples. Serum/plasma-based controls offer a direct and accurate way to
monitor the accuracy and precision of these tests, thus supporting the largest
share.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3447
Among the technology, in 2023, the
immunoassay/immunochemistry segment is expected to account for the largest
share of the IVD quality control market. Immunoassay/immunochemistry
advantages, such as inherent specificity, high-throughput, high sensitivity,
and low cost, are driving the growth of this technology segment. Further, the
increasing use of immunoassays in POC & infectious disease testing,
development of novel tests, increasing usage of miniaturized devices, and
rising demand for immunoassay-based tests support the increased demand for IVD
quality controls for immunoassays.
Among the applications, in 2023, the
infectious diseases segment is expected to account for the largest share of
the IVD quality control market. The high prevalence of infectious diseases
such as HIV, dengue, influenza, and pneumonia, the emergence of pandemics such
as COVID-19, and supportive initiatives by public organizations to increase
diagnostic testing are the factors supporting the large market share of this
segment. For instance, According to UNAIDS estimates, in 2021, 38.4 million
people were living with HIV globally (36.7 million adults and 1.7 million
children aged 0–14 years). Additionally, in 2021, 1.5 million new cases of HIV
were reported globally. This increased the usage of quality controls for
infectious diseases.
Based on end user, in 2023, the
hospitals & clinics segment is expected to account for the largest share
of the IVD quality control market. The large market segment share is majorly
attributed to the increasing prevalence of healthcare-associated infections
(HAIs), the high volume of diagnostic tests conducted in hospitals, the growth
in healthcare expenditure, and the expansion of hospitals and clinics in
emerging markets. Additionally, during the COVID-19 pandemic, hospital
admissions increased with the number of hospitals, leading to the high
adoption of COVID-19 test quality controls in hospitals & clinics.
Based on geography, Asia-Pacific is
expected to register the highest growth rate over the forecast period. The
significantly growing IVD industry in the region with rising demand for early
diagnosis from the large patient population in Asia, rising number of
accredited laboratories, increasing number of hospitals and clinical
pathologies, increasing healthcare spending, and improving healthcare
infrastructure in the region are some of the major drivers for the growth of
the Asia-Pacific market.
Quick Buy: https://www.meticulousresearch.com/Checkout/68741959
Key questions answered in
the report:
· What are
the high-growth market segments in terms of the offering, technology,
application, end user, and country/region?
· What was
the historical market for IVD quality control across the globe?
· What are
the market forecasts and estimates for 2023–2030?
· What are
the major drivers, restraints, opportunities, and challenges in the global IVD
quality control market?
· Who are
the major players in the global IVD quality control market?
· How is the
competitive landscape, and who are the market leaders in the global IVD
quality control market?
· What are
the recent developments in the IVD quality control market?
· What are
the different strategies adopted by the major players in the IVD quality
control market?
· What are
the geographic trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment